Frequency Therapeutics Earnings Estimate

KRRO Stock   11.17  0.59  5.02%   
The next projected EPS of Frequency Therapeutics is estimated to be -2.26345 with future projections ranging from a low of -2.425 to a high of -1.965. Frequency Therapeutics' most recent 12-month trailing earnings per share (EPS TTM) is at -9.42. Please be aware that the consensus of earnings estimates for Frequency Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Frequency Therapeutics is projected to generate -2.26345 in earnings per share on the 31st of December 2025. Frequency Therapeutics earnings estimates show analyst consensus about projected Frequency Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Frequency Therapeutics' historical volatility. Many public companies, such as Frequency Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Frequency Therapeutics' earnings estimates, investors can diagnose different trends across Frequency Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. As of the 14th of February 2026, Gross Profit is likely to drop to about 1.9 M. In addition to that, Pretax Profit Margin is likely to grow to -40.14Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

Frequency Therapeutics Earnings Estimation Breakdown

The calculation of Frequency Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Frequency Therapeutics is estimated to be -2.26345 with the future projection ranging from a low of -2.425 to a high of -1.965. Please be aware that this consensus of annual earnings estimates for Frequency Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-1.92
-2.42
Lowest
Expected EPS
-2.26345
-1.97
Highest

Frequency Therapeutics Earnings Projection Consensus

Suppose the current estimates of Frequency Therapeutics' value are higher than the current market price of the Frequency Therapeutics stock. In this case, investors may conclude that Frequency Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Frequency Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
976.48%
-1.92
-2.26345
-9.42

Frequency Therapeutics Earnings per Share Projection vs Actual

Actual Earning per Share of Frequency Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Frequency Therapeutics predict the company's earnings will be in the future. The higher the earnings per share of Frequency Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Frequency Therapeutics Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Frequency Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Frequency Therapeutics should always be considered in relation to other companies to make a more educated investment decision.

Frequency Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Frequency Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-12
2025-09-30-2.27-1.920.3515 
2025-08-12
2025-06-30-2.17-2.74-0.5726 
2025-05-12
2025-03-31-2.6213-2.490.1313
2025-03-24
2024-12-31-2.5129-2.260.252910 
2024-11-01
2024-09-30-2.61-2.260.3513 
2024-08-08
2024-06-30-2.39-2.4287-0.0387
2024-05-14
2024-03-31-2.51-2.440.07
2024-03-26
2023-12-31-2.36-25.65-23.29986 
2023-11-02
2023-09-30-17.73-15.52.2312 
2023-08-10
2023-06-30-0.36-0.30.0616 
2023-05-12
2023-03-31-0.42-0.55-0.1330 
2023-03-10
2022-12-31-0.631-0.490.14122 
2022-11-08
2022-09-30-0.57-0.550.02
2022-08-09
2022-06-30-0.6633-0.610.0533
2022-05-04
2022-03-31-0.6359-0.67-0.0341
2022-03-15
2021-12-310.1527-0.62-0.7727506 
2021-11-15
2021-09-30-0.589-0.73-0.14123 
2021-08-12
2021-06-30-0.5086-0.52-0.0114
2021-05-13
2021-03-310.1375-0.6-0.7375536 
2021-03-29
2020-12-31-0.254-0.3-0.04618 
2020-11-16
2020-09-30-0.2775-0.160.117542 
2020-08-12
2020-06-30-0.19-0.190.0
2020-05-14
2020-03-31-0.17-0.160.01
2020-03-26
2019-12-310.1-0.19-0.29290 
2019-11-18
2019-09-30-3.42-0.732.6978 
2019-09-23
2019-06-300-0.28-0.28

About Frequency Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Frequency Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Frequency Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Frequency Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-239.9 M-227.9 M
Earnings Yield(0.28)(0.30)
Price Earnings Ratio(3.66)(3.84)
Price Earnings To Growth Ratio 0.06  0.05 

Pair Trading with Frequency Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Frequency Stock

  0.4DMAC DiaMedica TherapeuticsPairCorr
  0.37VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Will Biotechnology sector continue expanding? Could Frequency diversify its offerings? Factors like these will boost the valuation of Frequency Therapeutics. Expected growth trajectory for Frequency significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Frequency Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(9.42)
Revenue Per Share
0.786
Return On Assets
(0.29)
Return On Equity
(0.63)
Understanding Frequency Therapeutics requires distinguishing between market price and book value, where the latter reflects Frequency's accounting equity. The concept of intrinsic value - what Frequency Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Frequency Therapeutics' price substantially above or below its fundamental value.
Understanding that Frequency Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Frequency Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Frequency Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.